Zimmer Biomet income statement
In fiscal 2025, Zimmer Biomet reported revenue of $8.23bn, up 7.2% on the year before, operating income of $1.10bn (a 13.3% margin) and net income of $705m, or $3.55 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2007Dec 2007 | 2008Dec 2008 | 2009Dec 2009 | 2010Dec 2010 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3,898 | 4,121 | 4,095 | 4,220 | 7,668 | 7,803 | 7,933 | 7,982 | 6,128 | 6,827 | 6,940 | 7,394 | 7,679 | 8,232 | 8,509 |
| Cost of revenue | 876 | 997 | 991 | 1,012 | 2,382 | 2,133 | 2,272 | 2,253 | 1,824 | 1,960 | 2,020 | 2,084 | 2,191 | 2,494 | 2,563 |
| Gross profit | 3,022 | 3,124 | 3,105 | 3,208 | 5,287 | 5,670 | 5,661 | 5,730 | 4,303 | 4,867 | 4,920 | 5,310 | 5,487 | 5,738 | 5,946 |
| Research and development | 183 | 192 | 206 | 219 | 366 | 370 | 392 | 449 | 323 | 436 | 406 | 459 | 437 | 459 | 443 |
| Selling, general and administrative | 1,517 | 1,704 | 1,729 | 1,759 | 2,945 | 3,105 | 3,379 | 3,344 | 2,713 | 2,843 | 2,762 | 2,839 | 2,930 | 3,257 | 3,433 |
| Operating income | 1,128 | 1,090 | 1,019 | 917 | 821 | 799 | 34 | 1,138 | 83 | 860 | 696 | 1,278 | 1,286 | 1,098 | 1,205 |
| Interest expense | — | — | 22 | 60 | 358 | 328 | — | — | — | — | — | — | — | — | — |
| Net interest income | — | — | — | — | −355 | −325 | −289 | −227 | −212 | −208 | −165 | −201 | −218 | −293 | −289 |
| Income before tax | 1,132 | 1,122 | 998 | 860 | 400 | 465 | −271 | 906 | −105 | 499 | 404 | 1,067 | 1,037 | 831 | 934 |
| Income tax | 358 | 272 | 281 | 263 | 95 | −1,349 | 108 | −226 | −96 | 54 | 112 | 42 | 131 | 126 | 127 |
| Net income | 773 | 849 | 717 | 597 | 306 | 1,814 | −379 | 1,132 | −139 | 402 | 231 | 1,024 | 904 | 705 | 807 |
| Diluted EPS | $3.26 | $3.72 | $3.32 | $2.97 | $1.51 | $8.90 | −$1.86 | $5.47 | −$0.67 | $1.91 | $1.10 | $4.88 | $4.43 | $3.55 | $4.11 |
| Diluted shares (average) | 238m | 228m | 216m | 201m | 202m | 204m | 204m | 207m | 207m | 210m | 210m | 210m | 204m | 199m | 196m |
| EBITDA | 1,358 | 1,365 | 1,356 | 1,257 | 1,860 | 1,862 | 1,074 | 2,144 | 982 | 1,798 | 1,623 | 2,229 | 2,282 | 2,192 | 2,314 |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,824 | 2,023 | 1,909 | 2,077 | 2,001 | 2,244 | 2,087 | 2,177 |
| Cost of revenue | 539 | 587 | 550 | 592 | 559 | 792 | 576 | 636 |
| Gross profit | 1,286 | 1,437 | 1,359 | 1,485 | 1,442 | 1,451 | 1,511 | 1,542 |
| Research and development | 112 | 109 | 111 | 113 | 116 | 119 | 103 | 105 |
| Selling, general and administrative | 710 | 747 | 759 | 815 | 811 | 872 | 850 | 899 |
| Operating income | 280 | 389 | 292 | 300 | 351 | 155 | 373 | 326 |
| Net interest income | −54 | −62 | −66 | −79 | −75 | −72 | −69 | −73 |
| Income before tax | 230 | 289 | 229 | 225 | 279 | 98 | 301 | 255 |
| Income tax | −19 | 49 | 47 | 71 | 48 | −40 | 63 | 56 |
| Net income | 249 | 240 | 182 | 153 | 231 | 139 | 238 | 198 |
| Diluted EPS | $1.23 | $1.19 | $0.91 | $0.77 | $1.16 | $0.71 | $1.22 | $1.03 |
| EBITDA | 530 | 653 | 547 | 572 | 635 | 439 | 643 | 597 |
Compare with peers
- Alcon Inc income statement
- Edwards Lifesciences income statement
- Intuitive Surgical income statement
- Baxter International income statement
- Steris income statement
Head to head: ALC vs ZBHEW vs ZBHISRG vs ZBHBAX vs ZBH
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies